BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | +50.0% | 13,900 | +23.3% | 0.00% | +50.0% |
| Q3 2019 | $12,000 | -50.0% | 11,270 | -18.9% | 0.00% | -50.0% |
| Q2 2019 | $24,000 | -48.9% | 13,900 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $47,000 | +14.6% | 13,900 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $41,000 | -60.6% | 13,900 | -17.8% | 0.01% | -55.6% |
| Q3 2018 | $104,000 | +1.0% | 16,900 | +21.6% | 0.02% | -5.3% |
| Q2 2018 | $103,000 | +13.2% | 13,900 | 0.0% | 0.02% | +11.8% |
| Q1 2018 | $91,000 | -54.7% | 13,900 | -41.8% | 0.02% | -52.8% |
| Q4 2017 | $201,000 | -51.6% | 23,900 | -33.4% | 0.04% | -53.8% |
| Q3 2017 | $415,000 | -47.9% | 35,900 | -47.4% | 0.08% | -49.7% |
| Q2 2017 | $797,000 | -15.1% | 68,271 | -10.3% | 0.16% | -15.8% |
| Q1 2017 | $939,000 | -9.5% | 76,112 | 0.0% | 0.18% | -14.4% |
| Q4 2016 | $1,037,000 | -34.5% | 76,112 | -4.4% | 0.22% | -36.6% |
| Q3 2016 | $1,584,000 | +44.4% | 79,612 | -5.9% | 0.34% | +37.8% |
| Q2 2016 | $1,097,000 | +38.7% | 84,612 | 0.0% | 0.25% | +32.3% |
| Q1 2016 | $791,000 | +15.3% | 84,612 | +150.1% | 0.19% | +3.9% |
| Q4 2015 | $686,000 | +181.1% | 33,836 | +101.8% | 0.18% | +163.2% |
| Q3 2015 | $244,000 | – | 16,770 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|